Cost-utility analysis of dimethyl fumarate compared with teriflunomide for the treatment of relapsing multiple sclerosis in China

RUI Mingjun, DU Xiwen, XIE Li, CAO Haijun, YIN Jian

PDF(1862 KB)
主办：上海医药工业研究院
　　　中国药学会
ISSN 1672-9188   CN 31-1939/R   SLYHAA
World Clinical Drug
PDF(1862 KB)
World Clinical Drug ›› 2022, Vol. 43 ›› Issue (11) : 1475-1485. DOI: 10.13683/j.wph.2022.11.015
Article

Cost-utility analysis of dimethyl fumarate compared with teriflunomide for the treatment of relapsing multiple sclerosis in China

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2022, 43(11): 1475-1485 https://doi.org/10.13683/j.wph.2022.11.015

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1862 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉